Gilead And AbbVie Are Not The Only Ones Re-Thinking CD47 Immunotherapies

Setback Hitting Plans For Big And Small Companies

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.